Intraabdominal Infections
"Intraabdominal Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.
| Descriptor ID |
D059413
|
| MeSH Number(s) |
C01.539.463
|
| Concept/Terms |
Intraabdominal Infections- Intraabdominal Infections
- Infection, Intraabdominal
- Infections, Intraabdominal
- Intraabdominal Infection
- Intra-Abdominal Infections
- Infection, Intra-Abdominal
- Infections, Intra-Abdominal
- Intra Abdominal Infections
- Intra-Abdominal Infection
|
Below are MeSH descriptors whose meaning is more general than "Intraabdominal Infections".
Below are MeSH descriptors whose meaning is more specific than "Intraabdominal Infections".
This graph shows the total number of publications written about "Intraabdominal Infections" by people in this website by year, and whether "Intraabdominal Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 8 | 4 | 12 |
| 2018 | 11 | 3 | 14 |
| 2019 | 7 | 1 | 8 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Intraabdominal Infections" by people in Profiles.
-
COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases. J Infect. 2021 07; 83(1):e37-e39.
-
The Safety of Eravacycline in the Treatment of Acute Bacterial Infection. Clin Infect Dis. 2020 06 10; 70(12):2750-2751.
-
The CABI Trial: an Unblinded Parallel Group Randomised Controlled Feasibility Trial of Long-Course Antibiotic Therapy (28 Days) Compared with Short Course (= 10 Days) in the Prevention of Relapse in Adults Treated for Complicated Intra-Abdominal Infection. J Gastrointest Surg. 2021 04; 25(4):1045-1052.
-
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART). J Glob Antimicrob Resist. 2020 06; 21:91-98.
-
IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections. Clin Infect Dis. 2019 08 30; 69(6):921-929.
-
Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection. J Crit Care. 2019 08; 52:258-264.
-
Source control and intra-abdominal infections: Still many questions and only limited answers. J Crit Care. 2019 08; 52:265-266.
-
Effect of physostigmine on recovery from septic shock following intra-abdominal infection - Results from a randomized, double-blind, placebo-controlled, monocentric pilot trial (Anticholium® per Se). J Crit Care. 2019 08; 52:126-135.
-
New antimicrobial options for the management of complicated intra-abdominal infections. Eur J Clin Microbiol Infect Dis. 2019 May; 38(5):819-827.
-
Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017). Rev Esp Quimioter. 2019 Apr; 32(2):145-155.